StairMed raises 350 million yuan in Series B funding, the largest investment in China's implantable BCI sector

StairMed/Implanted BCI (Ultra-flexible Electrodes)

StairMed announced a 350 million yuan ($48 million) Series B funding round, the largest single investment in China's implantable brain-machine interface sector. The round was led by Qiming Venture Partners, OrbiMed and Lilly Asia Ventures, and will support clinical trial acceleration, next-generation R&D and construction of a medical-grade microelectromechanical systems facility.